Best Initiative Awards 2018 Awarded Best Product by Correo Farmacéutico.

  • Aboca’s integrated research and development rewarded again in Spain.
  • In the year of its 40th Anniversary, the company wins recognition for its latest strategic launch.

April 2018 - Aboca, a company that, when it comes to developing new products, carries out integrated research in a systematic way and with a constant desire for improvement, has once again been awarded for one of its strategic launches.

Once again, the judges of the prestigious Best Initiative Awards, which this year celebrated its XVI edition, a demonstration of its consolidation in the sector, chose an Aboca product, COLILEN IBS, as an innovation worthy of recognition.

Aboca has taken the award in the Spanish capital of  Madrid in the magnificent setting of the Teatros del Canal, the perfect setting for a gala held on March 9th and which also this year brought together over 600 people: from eminent public and private health authorities to the most influential members of the pharmaceutical industry and health sector, everyone wanted to attend and share this moment that ever since the beginning has been an unmissable event.

Aboca is once again thankful for this recognition of the work it does every day, and it will act as one more motivation to keep working and researching into the plant-based molecular complexes that make up its product range dedicated to improving health.

With the notarial deed of 24th August 2018, Aboca changes its articles of association and becomes a Benefit Corporation...
Voted by Portuguese pharmacies, GrinTuss wins the Almofariz prize for “Best Product of the Year” 2018, organised by the...
COLILEN IBS wins the iDermo Bronze Award for Most Innovative Product in Pharmacy
Barcelona, ​​7th June - At the awards ceremony held this 5th June and celebrated at La Pedrera in Barcelona, ​​one of...